All In Biotech

Drug Trial Radar · NCT02660944

A Phase 2a of RSLV-132 in Subjects With Systemic Lupus Erythematosus (SLE)

A Phase 2a, Double-blind, Placebo-Controlled Study of RSLV-132 in Subjects With Systemic Lupus Erythematosus (SLE)

Last checked: Nov 20, 2026Latest source record: Mar 10, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

64

Actual

Start

Jan 3, 2016

Primary completion

May 28, 2020

Study completion Aug 10, 2020

Sponsor

Lead sponsor
Resolve TherapeuticsIndustry
Sponsor type
Industry
First posted
Jan 21, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study evaluates the impact of 13 bi-weekly intravenous infusions of RSLV-132 on the cutaneous manifestations in subjects with systemic lupus erythematosus.

Conditions

  • Systemic Lupus Erythematosus

Interventions

  • RSLV-132Drug

    RNase-Fc fusion protein

  • PlaceboDrug

    Saline placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) Improvement Compared to Placebo.Time frame: Baseline and Days 29, 57, 85, 99, 113, 127, 141, 155, 169

Locations

16 sites in 1 country. Site status is shown where the registry gives one.

  • TriWest Research Associates

    El Cajon, California

  • University of California San Diego

    La Jolla, California

  • Valerius Research Center

    Los Alamitos, California

  • Wallace Rheumatic Study Center

    Los Angeles, California

  • University of Colorado

    Aurora, Colorado

  • Clinical Research of West Florida

    Clearwater, Florida

  • Center for Rheumatology, Immunology and Arthritis

    Fort Lauderdale, Florida

  • Alper Research

    Naples, Florida

  • Northwell Health/ Division of Rheumatology

    Great Neck, New York

  • Feinstein Institute for Medical Research

    Manhasset, New York

  • DJL Clinical Research

    Charlotte, North Carolina

  • Cleveland Clinic

    Cleveland, Ohio

  • Temple University

    Philadelphia, Pennsylvania

  • Vanderbilt University

    Nashville, Tennessee

  • Metroplex Clinical Research Center

    Dallas, Texas

  • Accurate Clinical Research

    Sugar Land, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.